MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Inflammatory Bowel Disease
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

6,452 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
6,452 works in the cohort · of 4,299,418page 29 of 130

Labels cover 21 of 6,452 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 6,452 of 6,452 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis
Heinfried H. Radeke, Jürgen M. Stein, Gert Van Assche, Gerhard Rogler, Péter L. Lakatos, Florian Muellershausen +5 more
2020· article· en· Inflammatory Intestinal Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
40
citations
affunlabeled
Design Issues and Outcomes in Ibd Clinical Trials
Bruce E. Sands, María T. Abreu, George D. Ferry, Anne M. Griffiths, Stephen B. Hanauer, Kim L. Isaacs +3 more
2005· review· en· Inflammatory Bowel Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · metaresearchconsensus · metaresearch
40
citations
aboutno affunlabeled
Risk Factors for Osteoporosis in Crohnʼs Disease
Neville Azzopardi, Pierre Ellul
2013· article· en· Inflammatory Bowel Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
40
citations
affunlabeled
Standard Treatment of Ulcerative Colitis
Paolo Gionchetti, Fernando Rizzello, Flavio Habal, Claudia Morselli, C. Amadini, Massimo Campieri
2003· article· en· Digestive Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
39
citations
affaboutunlabeled
Infliximab in Ulcerative Colitis
Sarah E. Moore, Kimberlyn McGrail, Sandra E. Peterson, Manoj J. Raval, Ahmer Karimuddin, P. Terry Phang +2 more
2013· article· en· Diseases of the Colon & Rectum· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
39
citations
venueno affunlabeled
Inflammatory Bowel Diseases and Spondyloarthropathies
Paolo Gionchetti, Carlo Calabrese, F. Rizzello
2015· article· en· Journal of Rheumatology Supplement· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
39
citations

How this was built: Screen · Findings · About